Provention Bio is developing a coxsackievirus vaccine that it hopes could prevent up to 50% of Type 1 diabetes cases.[...

In mouse models of triple-negative breast cancer, the protein Tinagl1 blocked two cancer promoters, epidermal growth factor receptor and focal adhesion kinase. (Nat...

Takeda is moving further into the growing field of cell therapy through new and expanded collaborations aimed at developing drugs for hard-to-treat blood cancers ...

Scientists from Cardiff University have uncovered a protein which drives aggressive breast cancer and could be targeted for developing new and improved therapies. Pr...

Heidelberg, Germany, January 07, 2019 / B3C newswire / -- Velabs Therapeutics, specializing in the fast generation of functional therapeutic antibodies, today announc...

Northwestern Medicine scientists have discovered two successful therapies that slowed the progression of pediatric leukemia in mice, according to three studies publis...

Some patients with breast cancer receive chemotherapy before the tumor is removed with surgery. This approach, called 'neoadjuvant' therapy, helps to reduce the size ...

Hundreds of new genes linked to blindness and other vision disorders have been identified in a screen of mouse strains. Many of these genes are likely important in hu...

Scientists have found that cell-free DNA (cfDNA) within in the blood can reflect differences in the age and health of individuals. cfDNA refers to naked DNA fragme...

One-time treatment with an experimental gene therapy for spinal muscular atrophy could be more cost effective than Biogen's marketed drug Spinraza, even at a price...